Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,878,421
-
Share change
-
-223,047
-
Total reported value
-
$135,043,089
-
Price per share
-
$34.82
-
Number of holders
-
90
-
Value change
-
-$9,584,409
-
Number of buys
-
44
-
Number of sells
-
47
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q1 2016
As of 31 Mar 2016,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
90 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,878,421 shares.
The largest 10 holders included
Abdiel Capital Advisors, LP, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, RK Capital Management, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, Elk Creek Partners, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
90
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.